Header Logo

Connection

HELEN HESLOP to Oncolytic Viruses

Back to Details
This is a "connection" page, showing publications HELEN HESLOP has written about Oncolytic Viruses.
HELEN HESLOP
Connection Strength
0.180
Oncolytic Viruses
  1. Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies. Sci Adv. 2023 03 29; 9(13):eade6790.
    View in: PubMed
    Score: 0.180
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.